MNX Market Network Exchange
Commercial intelligence · New York
Menu
$1,000The New York strategy we build for retained clients, made accessible.Build my strategy →

New York policy

S11: Requires disclosure of information concerning non-invasive prenatal screening for chromosomal abnormalities

NY Senate · Sponsor James Skoufis

Jurisdiction
New York State
Applies to
New York State (proposed)
Effective
February 3, 2026

What it requires

Requires disclosure of information concerning non-invasive prenatal screening for chromosomal abnormalities including the benefits and limitations of non-invasive prenatal testing, the difference between non-invasive prenatal testing and prenatal diagnostic testing, and current recommendations from the American College of Obstetricians and Gynecologists (ACOG), the Society for Maternal Fetal Medicine, and the American College of Medical Genetics and Genomics (ACMG).

ny-statesenatelegislationbill

Official source ↗

Free account

Create a free account

Track New York policy and save searches across the Network. Free. No card required.

Want to turn policy like this into market and network moves? Build your Market Network Strategic Plan →